Hubei Jumpcan Pharmaceutical Co., Ltd.
600566
Kedudukan dalam Saham
#4335
Hubei Jumpcan Pharmaceutical Co., Ltd. is a Chinese enterprise dedicated to the... Hubei Jumpcan Pharmaceutical Co., Ltd. is a Chinese enterprise dedicated to the full spectrum of pharmaceutical operations, encompassing research, development, production, and marketing. The company's product lines include both traditional Chinese and Western medicines, as well as daily-use chemical products incorporating traditional Chinese medicine, and health supplements rooted in Chinese medical practices. Their diverse range of Chinese and Western pharmaceuticals addresses a wide array of therapeutic areas, such as pediatric care, women's health, respiratory conditions, digestive disorders, and geriatric medicine. Additionally, their development pipeline covers treatments for detoxification, nervous system ailments, anti-infective agents, cardiovascular issues, pain relief, nutritional deficiencies, musculoskeletal problems, and blood clotting management. Beyond medicinal products, Jumpcan also manufactures oral and skin care items. The company's Chinese medicine-based health products are designed to provide benefits like fatigue reduction, anti-aging effects, antioxidant support, and immune system boosting. Headquartered in Taixing, China, the company adopted its current name, Hubei Jumpcan Pharmaceutical Co., Ltd., in March 2015, having previously operated as Hubei Hongcheng General Machinery Co., Ltd.
Harga Saham
$3.87
Modal Pasaran
$3.57B
Perubahan (1 hari)
-1.64%
Perubahan (1 tahun)
9.08%
Negara
CN
Perdagangan Hubei Jumpcan Pharmaceutical Co., Ltd. (600566)
Kategori
Healthcare
Hasil untuk Hubei Jumpcan Pharmaceutical Co., Ltd. (600566)
Hasil pada Oct 2026 TTM: 0
Menurut laporan kewangan terkini daripada Hubei Jumpcan Pharmaceutical Co., Ltd., hasil semasa syarikat (TTM) ialah 0. Pada tahun 2026, syarikat memperoleh hasil sebanyak 0 sama dengan hasil pada tahun 2026 iaitu 0. Hasil ialah jumlah pendapatan keseluruhan yang dijana oleh syarikat daripada jualan barangan atau perkhidmatan. Tidak seperti keuntungan, tiada perbelanjaan ditolak.
Sejarah hasil bagi Hubei Jumpcan Pharmaceutical Co., Ltd. dari 2001 hingga 2026
Hasil pada akhir setiap tahun
| Tahun | Hasil | Ubah |
|---|---|---|
| 2025 | $888.83M | -19.07% |
| 2024 | $1.10B | -19.47% |
| 2023 | $1.36B | 4.58% |
| 2022 | $1.30B | 8.64% |
| 2021 | $1.20B | 27.21% |
| 2020 | $943.71M | -5.31% |
| 2019 | $996.65M | -4.89% |
| 2018 | $1.05B | 20.84% |
| 2017 | $867.17M | 28.71% |
| 2016 | $673.77M | 16.12% |
| 2015 | $580.22M | 20.34% |
| 2014 | $482.15M | 19.49% |
| 2013 | $403.51M | 31.04% |
| 2012 | $307.92M | 707.24% |
| 2011 | $38.14M | 6.17% |
| 2010 | $35.93M | 10.48% |
| 2009 | $32.52M | 4.19% |
| 2008 | $31.21M | 4.28% |
| 2007 | $29.93M | 16.41% |
| 2006 | $25.71M | 17.82% |
| 2005 | $21.82M | 23.58% |
| 2004 | $17.66M | 28.84% |
| 2003 | $13.71M | 5.73% |
| 2002 | $12.96M | -5.87% |
| 2001 | $13.77M | 0.00% |
Hasil untuk syarikat atau pesaing serupa
| Syarikat | Hasil | Perbezaan Hasil | Negara |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $6.61B | - |
IN
|
